Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurosh Gharagozli

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annals of Indian Academy of Neurology|January 30, 2019
Newer Antiepileptic Drugs Discontinuation due to Adverse Effects: An Observational StudyMehdi Golpayegani, Farhad Salari, Kurosh Gharagozli
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2003
Multiple sclerosis: report on 200 cases from IranHossein Kalanie, Kurosh Gharagozli, Amir Reza Kalanie
Gene|August 29, 2017
Thioredoxin-1, redox factor-1 and thioredoxin-interacting protein, mRNAs are differentially expressed in Multiple Sclerosis patients exposed and non-exposed to interferon and immunosuppressive treatmentsElham Mahmoudian, Ahad Khalilnezhad, Kurosh Gharagozli, et al.
Seizure|August 25, 2018
Two predictors of postictal generalized EEG suppression: Tonic phase duration and postictal immobility periodMarjan Asadollahi, Mahyar Noorbakhsh, Leila Simani, et al.
Neuropsychiatric Disease and Treatment|August 9, 2020
Evaluation of Fear in Idiopathic Epilepsy Using Population-Based Survey and Bhalla-Gharagozli Fear in Epilepsy Questionnaire (BG-FEQ)Kurosh Gharagozli, Elham Lotfalinezhad, Fatemeh Amini, et al.
Case Reports in Medicine|June 2, 2011
Myasthenia gravis development and crisis subsequent to multiple sclerosisKurosh Gharagozli, Maziar Shojaei, Ali Amini Harandi, et al.
European Neurology|November 13, 2004
Interferon Beta-1a and intravenous immunoglobulin treatment for multiple sclerosis in IranHossein Kalanie, Kurosh Gharagozli, Abolfazl Hemmatie, et al.
Iranian Journal of Neurology|November 20, 2013
Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosisKurosh Gharagozli, Leila Poorsaadat, Ali Amini Harandi, et al.
Cellular and Molecular Neurobiology|December 23, 2006
Do haplogroups H and U act to increase the penetrance of Alzheimer's disease?Farzaneh Fesahat, Massoud Houshmand, Mehdi Shafa Shariat Panahi, et al.
Neurology Research International|November 9, 2020
Medication Beliefs and Adherence to Antiseizure MedicationsDevender Bhalla, Elham Lotfalinezhad, Fatemeh Amini, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of Indian Academy of Neurology|January 30, 2019
Newer Antiepileptic Drugs Discontinuation due to Adverse Effects: An Observational StudyMehdi Golpayegani, Farhad Salari, Kurosh Gharagozli
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 6, 2003
Multiple sclerosis: report on 200 cases from IranHossein Kalanie, Kurosh Gharagozli, Amir Reza Kalanie
Gene|August 29, 2017
Thioredoxin-1, redox factor-1 and thioredoxin-interacting protein, mRNAs are differentially expressed in Multiple Sclerosis patients exposed and non-exposed to interferon and immunosuppressive treatmentsElham Mahmoudian, Ahad Khalilnezhad, Kurosh Gharagozli, et al.
Seizure|August 25, 2018
Two predictors of postictal generalized EEG suppression: Tonic phase duration and postictal immobility periodMarjan Asadollahi, Mahyar Noorbakhsh, Leila Simani, et al.
Neuropsychiatric Disease and Treatment|August 9, 2020
Evaluation of Fear in Idiopathic Epilepsy Using Population-Based Survey and Bhalla-Gharagozli Fear in Epilepsy Questionnaire (BG-FEQ)Kurosh Gharagozli, Elham Lotfalinezhad, Fatemeh Amini, et al.
Case Reports in Medicine|June 2, 2011
Myasthenia gravis development and crisis subsequent to multiple sclerosisKurosh Gharagozli, Maziar Shojaei, Ali Amini Harandi, et al.
European Neurology|November 13, 2004
Interferon Beta-1a and intravenous immunoglobulin treatment for multiple sclerosis in IranHossein Kalanie, Kurosh Gharagozli, Abolfazl Hemmatie, et al.
Iranian Journal of Neurology|November 20, 2013
Frequency distribution of the first clinical symptoms in the Iranian population with multiple sclerosisKurosh Gharagozli, Leila Poorsaadat, Ali Amini Harandi, et al.
Cellular and Molecular Neurobiology|December 23, 2006
Do haplogroups H and U act to increase the penetrance of Alzheimer's disease?Farzaneh Fesahat, Massoud Houshmand, Mehdi Shafa Shariat Panahi, et al.
Neurology Research International|November 9, 2020
Medication Beliefs and Adherence to Antiseizure MedicationsDevender Bhalla, Elham Lotfalinezhad, Fatemeh Amini, et al.
Pageof 2